NEW YORK (GenomeWeb News) – A consortium of European research partners will use €9.5 million ($12.3 million) from the EU to trawl the trenches of the deep seas in search of organisms that could be used to develop bioactive compounds for treating diseases and for nutritional and cosmetic applications.

Led by researchers at the University of Aberdeen and the University of Leuven, the 24 PharmSea initiative partners from 14 countries will collect and screen mud and sediment samples from deep oceanic trenches to discover those compounds, KU Leuven said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.